1352227-15-6

Basic information

• Product Name: (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine
• Synonyms: (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine;EOS-61597
• CAS NO: 1352227-15-6
• Molecular Formula: C₁₁H₁₆ClN₃OS
• Molecular Weight: 273.78224
• Mol File: 1352227-15-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 466.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.256±0.06 g/cm3(Predicted)
• PKA: 3.32±0.43(Predicted)
• CAS DataBase Reference: (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine(1352227-15-6)
• EPA Substance Registry System: (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine(1352227-15-6)

Safety Data

• Hazardous Substances Data: 1352227-15-6(Hazardous Substances Data)

Usage

Description

(R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine is a complex chiral chemical compound characterized by a pyrimidine ring with a chloro group and a methylthiomethyl group attached, as well as a morpholine ring with a methyl group. (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine's unique structure and chirality may offer potential applications across various industries, including pharmaceuticals and agriculture, and it could serve as a building block for more complex organic molecules, making it a subject of interest for scientific research and drug development.

Uses

Used in Pharmaceutical Industry:
(R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine is used as a potential pharmaceutical compound for its unique molecular structure and chirality, which may contribute to the development of new drugs and therapies.
Used in Agricultural Industry:
In the agricultural sector, (R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine could be utilized as a building block for the synthesis of novel agrochemicals, potentially leading to the creation of more effective pesticides or other agricultural products.
Used in Chemical Research:
(R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine is used as a subject of interest in chemical research due to its complex molecular structure and chirality, which may provide insights into new synthetic pathways and the development of advanced organic molecules.
Used in Drug Development:
(R)-4-(2-chloro-6-(methylthiomethyl)pyrimidin-4-yl)-3-methylmorpholine is used as a potential candidate in drug development, leveraging its unique structural features to design and synthesize new pharmaceutical agents with specific therapeutic targets.

Upstream product

• 1233339-72-4 (3R)-4-[2-chloro-6-(iodomethyl)pyrimidin-4-yl]-3-methylmorpholine 
• 5188-07-8 sodium thiomethoxide 
• 74572-04-6 (3R)-3-methylmorpholine 
• 6299-85-0 2,6-dichloropyrimidine-4-carboxylic acid methyl ester 
• 1233339-70-2 [2-chloro-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl]methanol 
• 1233339-71-3 [2-chloro-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-4-yl]methyl methanesulfonate 
• 1352227-14-5 (R)-4-(2-chloro-6-(chloromethyl)pyrimidin-4-yl)-3-methylmorpholine 
• 1233339-69-9 methyl 2-chloro-6-[(3R)-3-methylmorpholin-4-yl]pyrimidine-4-carboxylate 

Downstream Products

• 1352232-88-2 (3R)-3-methyl-4-(6-(1-(S-methylsulfonimidoyl)cyclopropyl)-2-(1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-yl)pyrimidin-4-yl)morpholine 
• 1352227-13-4 (R)-3-methyl-4-(6-((R)-S-methylsulfonimidoylmethyl)-2-(1-tosyl-1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)morpholine 
• 1352226-88-0 4-[4-[1-[[S(R)]-S-methylsulfonimidoyl]cyclopropyl]-6-[(3R)-3-methyl-4-morpholinyl]-2-pyrimidinyl]-1H-pyrrolo[2,3-b]pyridine 
• 1352226-87-9 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((S)-S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine 
• 1352232-89-3 (3R)-3-methyl-4-(6-(1-((R)-S-methylsulfonimidoyl)cyclopropyl)-2-(1-tosyl-1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)morpholine 

Relevant articles and documents

Pyrimidine derivative, and preparation method and application thereof

The invention discloses a compound represented by general formula (I) capable of being used as an ATR protein kinase inhibitor, and an isomer or pharmaceutically acceptable salt thereof. The compound, and the isomer or the pharmaceutically acceptable salt thereof can be used for preparing medicines for treating and/or preventing hyperproliferative diseases.

Development and Scale-up of a Route to ATR Inhibitor AZD6738

AZD6738 is currently being tested in multiple phase I/II trials for the treatment of cancer. Its structure, comprising a pyrimidine core decorated with a chiral morpholine, a cyclopropyl sulfoximine, and an azaindole, make it a challenging molecule to syn

Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent

The kinase ataxia telangiectasia mutated and rad3 related (ATR) is a key regulator of the DNA-damage response and the apical kinase which orchestrates the cellular processes that repair stalled replication forks (replication stress) and associated DNA double-strand breaks. Inhibition of repair pathways mediated by ATR in a context where alternative pathways are less active is expected to aid clinical response by increasing replication stress. Here we describe the development of the clinical candidate 2 (AZD6738), a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. Compound 2 was developed improving aqueous solubility and eliminating CYP3A4 time-dependent inhibition starting from the earlier described inhibitor 1 (AZ20). The clinical candidate 2 has favorable human PK suitable for once or twice daily dosing and achieves biologically effective exposure at moderate doses. Compound 2 is currently being tested in multiple phase I/II trials as an anticancer agent.